Neurology Central

Huntington’s pathology alleviated by CRISPR/Cas9 gene editing

An international team of researchers has utilized CRISPR/Cas9 gene editing to reverse Huntington’s disease (HD) pathology in a mouse model. The findings could open up new treatment avenues for HD and other inherited neurodegenerative diseases.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.